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Edited by Thomas So¨llnerAbstract Enveloped viruses exit their host cell by budding from
a cellular membrane and thereby spread from one cell to another.
Virus budding in general involves the distortion of a cellular
membrane away from the cytoplasm, envelopment of the viral
capsid by one or more lipid bilayers that are enriched in viral
membrane glycoproteins, and a ﬁssion event that separates the
enveloped virion from the cellular membrane. While it was ini-
tially thought that virus budding is always driven by viral trans-
membrane proteins interacting with the inner structural proteins,
it is now clear that the driving force may be diﬀerent depending
on the virus. Research over the past years has shown that viral
components speciﬁcally interact with host cell lipids and pro-
teins, thereby adopting cellular functions and pathways to facil-
itate virus release. This review summarizes the current
knowledge of the cellular membrane systems that serve as viral
budding sites and of the viral and cellular factors involved in bud-
ding. One of the best studied cellular machineries required for
virus egress is the ESCRT complex, which will be described in
more detail.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Replication of viruses is intrinsically tied to their host cell.
Viral spread, however, depends on an extracellular step in
the replication cycle, involving the release of virus particles
from an infected host cell and subsequent infection of a target
cell. Most non-enveloped viruses exit their host cells by lysis,
which involves breakdown of the cell membrane and death
of the host cell. In contrast, enveloped viruses are released
via budding at a host cell membrane, thereby acquiring a
cell-derived membrane containing viral (and sometimes cellu-
lar) proteins. Virus egress by budding maintains the integrity
of the host cell membrane and thus allows regulated produc-
tion without necessarily killing the producing cell. Further-
more, enveloped viruses can enter target cells via fusion with
cellular membranes. Thus, the ability of enveloped viruses to*Corresponding author. Fax: +49 6221 565003.
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(by fusion) without compromising membrane integrity in-
creases the eﬃcacy of viral spread and gives directionality to
the viral release-entry process that can be temporally regulated
at various stages. This confers evolutionary advantages on
enveloped animal viruses, since plant viruses and bacterio-
phages have to cross a cell wall for exit and entry and therefore
beneﬁt less from the advantages of membrane fusion.
Virus budding can be deﬁned as the envelopment of a viral
core by a cellular membrane containing viral glycoproteins
and subsequent membrane ﬁssion to release the particle from
the membrane. When budding occurs at the plasma mem-
brane, virions are directly released into the extracellular space,
and many viruses such as retroviruses, alphaviruses, rhabdovi-
ruses, and ortho- and paramyxoviruses have been shown to
bud predominantly at the surface of infected host cells. How-
ever, virus budding can also occur on intracellular membranes,
resulting in the accumulation of particles in the lumen of cellu-
lar organelles. A wide variety of intracellular membranes such
as the nuclear envelope (NE), rough and smooth endoplasmic
reticulum (ER), endosomes, intermediate or pre-Golgi com-
partment (IC), Golgi cisternae and the trans-Golgi-network
(TGN) have been proposed to serve as platforms for virus bud-
ding (Fig. 1). When budding occurs intracellularly, virus re-
lease requires the subsequent transport of virus-ﬁlled vesicles
towards the cell surface and their fusion with the plasma mem-
brane. This viral secretion step depends on cellular secretory
transport, which can be controlled and regulated by the virus
at various stages, allowing directed virus release, for instance
in a speciﬁc host cell environment.2. Cellular membrane platforms for virus budding
Besides the plasma membrane, various intracellular mem-
brane systems have been shown to serve as viral budding plat-
forms (Fig. 1). Budding sites have not been identiﬁed
unequivocally for all viruses, however, and the choice of bud-
ding site may also be cell-type dependent. For instance, the ret-
rovirus Human Immunodeﬁciency Virus type-1 (HIV-1) buds
almost exclusively from the cell surface of T cells and many cell
lines, while several lines of evidence indicated intracellular
budding in macrophages: (i) the observation of intracytoplas-
mic vacuoles into which HIV buds and accumulates (ii) local-
ization of endosomal marker proteins to both the limiting
membrane of these vacuolar structures and the viral envelope
and (iii) immunoprecipitation of infectious virus derived fromblished by Elsevier B.V. All rights reserved.
Fig. 1. Various membrane systems are implicated in budding of enveloped viruses. Many enveloped viruses (e.g. retroviruses, paramyxoviruses,
orthomyxoviruses, arenaviruses, ﬁloviruses, coronaviruses and some rhabdoviruses) bud from the plasma membrane of infected cells (depicted in
light blue). In the case of the retrovirus HIV-1, the limiting membrane of multivesicular bodies has also been implicated in virus budding, and it was
proposed that viruses exit cells in an exosome-like fashion. Many other viruses bud into the lumen of organelles along the secretory pathway (ER, IC,
Golgi and TGN). In such cases, viruses are often transported within secretory vesicles to the plasma membrane, where they are ﬁnally released from
the cell (red, brown, black). Members of the Flaviviridae family bud on membranes of the ER or ER-to-Golgi IC, resulting in accumulation of
enveloped virus particles in the lumen of the IC, followed by maturation in the Golgi or TGN, respectively (black). Similarly, Foamy Viruses,
‘unusual’ retroviruses, were proposed to bud into the lumen of the ER, from where enveloped particles are transported through the Golgi and TGN
to the plasma membrane (red). Most DNA viruses replicate in the nucleus, and therefore have to cross the NE prior to budding at cellular
membranes. In the case of Herpesviruses (brown), the viruses exit the nucleus by budding on the NE, followed by release of non-enveloped viral
capsids from the ER into the cytoplasm. In a second budding step, herpesviruses may bud on TGN-derived vesicles, from which viruses are ﬁnally
released. Vaccinia virus (pink), the prototype member of the Poxvirus family, is consecutively enveloped by several membrane layers, which are
presumably derived from the ER and the TGN, respectively. NE-nuclear envelope. ER-endoplasmic reticulum. IC-intermediate compartment. TGN-
trans-Golg network. MVB-multivesicular body.
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Based on this, it was proposed that HIV buds into multivesic-
ular bodies (MVBs) of macrophages. This appeared particu-
larly intriguing in view of the parallel identiﬁcation of the
cellular ESCRT-machinery, which mediates budding of intra-
lumenal vesicles into the MVB, as being essential for HIV re-
lease (see below). Intracellular budding and storage of
infectious virus could also allow for delayed and controlled
virus release, triggered by contact with a target cell [3]. More
recently, however, the role of intracellular compartments in
HIV budding has been questioned and it was argued that the
intracellular pool of viruses mainly represents re-internalized
particles that have originally budded from the plasma mem-
brane [4]. Recent work from our laboratory revealed that the
cell surface of macrophages displays deep invaginations into
which HIV particles can bud and where they accumulate, sup-
porting the notion that the plasma membrane is the primary
site of HIV budding also in macrophages [5]. Since macro-
phages are a major target for HIV infection in vivo, this clearly
remains an issue that needs further investigation.
Membrane envelopment of viral cores is more complex in
case of some DNA viruses such as the prototype member of
the Poxviridae family, Vaccinia Virus, which employs two dif-
ferent cellular membrane systems for primary and secondary
envelopment, respectively [6]. Intracellular mature viruses
(IMVs) are formed by envelopment of the viral core with mem-
branes that may be derived from the ER [7,8], whereas in a sec-
ond round of envelopment, some IMVs acquire additionalmembranes derived from the TGN [9]. These intracellular
enveloped viruses are released from the cell mainly via fusion
with the plasma membrane.
Most DNA viruses replicate in the nucleus, and their egress
therefore requires crossing of the nuclear envelope and, subse-
quently, the cell membrane. The ﬁrst step can be achieved by
transport of viral genomes – usually in a complex with viral
and cellular proteins – through nuclear pore complexes, fol-
lowed by budding on a cellular membrane in the second step.
The nucleocapsids of herpesviruses such as Herpes Simplex
Virus (HSV) are too large for nuclear export and herpesviruses
therefore leave the cell by consecutive envelopment, de-envel-
opment and re-envelopment processes [10]. HSV nucleocapsids
traverse the nuclear envelope by budding from the inner nucle-
ar membrane into the perinuclear cleft and subsequently lose
their temporary envelope by fusion with the outer nuclear
membrane (Fig. 1). Naked cytoplasmic nucleocapsids then ac-
quire their ﬁnal envelope by budding at a cellular membrane,
which may be derived from early endosomes, the IC or the
TGN ([10] and references therein).
Virus budding and its analogy to cellular envelopment pro-
cesses is of central interest for cell biology, since the identiﬁca-
tion of viral factors involved- and how they usurp cellular
machinery-yields important insights into cellular functions.
Furthermore, interfering with virus release is also a potential
approach for therapeutic intervention against viral infections,
thus warranting study of these processes also from a medical
point of view.
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Early studies in Semliki Forest virus (SFV)-infected cells
have shown that SFV budding requires recruitment of the viral
core by envelope glycoproteins. This led to the hypothesis that
the speciﬁc interaction of viral membrane glycoproteins with
inner structural proteins (matrix, core or capsid) is the driving
force for bud formation [11] (Fig. 2C). It was predicted that
this principle should apply to release of all enveloped viruses,
but later studies indicated that budding mechanisms vary for
diﬀerent virus families and that budding may be dependent
on viral envelope glycoproteins, inner core proteins or both.
Expression of coronavirus or ﬂavivirus glycoproteins without
any other viral components led to release of enveloped parti-
cles morphologically similar to complete virions [12,13]. Fur-
thermore, Hepatitis B Virus (HBV) surface glycoproteins can
be secreted as subviral particles in the absence of any other vir-
al component [14]. On the other hand, budding of most retro-
viruses (with the exception of Foamy Virus) occurs
independent of membrane glycoproteins and is exclusively dri-
ven by the major structural core protein, Gag [15]. Accord-
ingly, expression of Gag alone leads to the formation of
enveloped, morphologically normal virus-like particles (VLPs)
lacking viral glycoproteins at the plasma membrane. Later
studies showed that this also applies to other viruses that
bud at the plasma membrane, where expression of the viralFig. 2. Enveloped virus budding is driven by ‘pull’- or ‘push’-
mechanisms. (A) Viral membrane glycoproteins assemble on the
cellular membrane that serves as budding site, thereby creating a
‘pulling’ force that drives membrane curvature and bud formation. (B)
Inner viral structural proteins (I) or pre-assembled viral nucleocapsids
(II) attach to the cytoplasmic side of the budding site and create a
‘pushing’ force that drives membrane curvature and bud formation.
(C) Pushing and pulling forces can act in concert to drive virus
budding.matrix protein – forming a protein structure that supports
the inner face of the virion membrane – suﬃces for release
of enveloped VLPs (see below).
Taken together these data indicate that there is no common
principle that governs budding of all viruses. It is clear that
formation of fully infectious viruses always requires the pres-
ence of all components including glycoproteins, inner struc-
tural proteins and viral genomes, but the minimal
requirements that drive bud formation can be assigned to
either one of three classes: (i) Budding is primarily driven by
viral membrane glycoproteins. In such cases, glycoproteins
serve as ‘pulling’ forces assembling on the nascent viral mem-
brane (Fig. 2A). They often form a symmetric (e.g. icosahe-
dral) lattice that drives viral morphogenesis of, for instance
coronaviruses and ﬂaviviruses [12,13]. Expression of other vir-
al glycoproteins can lead to formation of extracellular vesicles
without a symmetrical structure [16], although this may be due
to induction of cellular vesiculation rather than an active bud-
ding process. (ii) Budding is driven by inner structural pro-
teins. As discussed above, this was initially observed for the
Gag protein of retroviruses. In this case, the driving force
assembles on the cytoplasmic side of the membrane and can
therefore be regarded as a ‘pushing’ force (Fig. 2B). This mech-
anism also applies to members of the families of rhabdoviruses
[17], ﬁloviruses (reviewed in [18]), arenaviruses [19] and para-
myxoviruses (reviewed in [20]), where expression of the viral
matrix protein is suﬃcient for release of VLPs resembling the
complete virion. (iii) Budding requires both viral core proteins
and glycoproteins, as is the case for SFV and most other
alphaviruses [21] (Fig. 2C). There are, however, exceptions:
Budding of the retrovirus Foamy virus and of SARS corona-
virus, for instance, depends on expression of the nucleocapsid
together with the viral glycoproteins [22,23]. Herpesviruses ap-
pear to diﬀer in their budding requirements, as they do not
contain typical viral matrix proteins (forming a lattice on the
cytosolic face of the membrane), but utilize viral tegument pro-
teins (forming a largely amorphous layer between the nucleo-
capsid and the membrane) to interact with the membrane
[24]. The identity of these tegument proteins diﬀers for the ﬁrst
and second envelopment step, consistent with budding occur-
ring at diﬀerent cellular membranes [10].4. Membrane association of viral components
A prerequisite for budding of infectious enveloped virus par-
ticles is the assembly of all virus components at a conjoint cel-
lular membrane. Viral membrane glycoproteins are, as a rule,
co-translationally inserted into ER membranes [25] and often
modiﬁed during their passage through the secretory pathway,
where they may be retained by speciﬁc signals. Endocytosis
motifs in the cytoplasmic tails of viral glycoproteins can medi-
ate re-localization from the cell surface to endosomal mem-
branes. For instance, retroviral Env glycoproteins were
shown to localize predominantly to intracellular endosomal
membranes at steady state due to highly conserved endocytosis
motifs [26,27].
The inner structural proteins of enveloped viruses that form
the viral core or capsid, on the other hand, generally lack
membrane-spanning domains and have to be anchored in or
associated with membranes containing the viral transmem-
brane proteins prior to or during budding. Co-localization of
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mechanisms: a simple approach is consecutive translation of
one single structural polyprotein that is inserted into a lipid bi-
layer. Proteolytic cleavage of the polyprotein then yields indi-
vidual capsid and glycoproteins, both of which remain
associated with the same membrane. For instance, all struc-
tural proteins of members of the Flaviviridae family including
Hepatitis C Virus are synthesized as a single polyprotein,
which is co-translationally inserted into the ER membrane (re-
viewed in [28]). Upon proteolytic cleavage, both the E1/E2 gly-
coproteins and the RNA-binding core protein remain
associated with the ER, thus ensuring co-localization of all
components prior to budding. Similarly, the structural pro-
teins of alphaviruses such as SFV are synthesized as a single
polyprotein on ER membranes [21]. The SFV capsid protein
C is, however, released into the cytoplasm upon proteolytic
cleavage, whereas the E1/E2 glycoprotein is targeted through
the secretory pathway towards the plasma membrane, where
C binds speciﬁcally. In this case, independent targeting of C
to the plasma membrane is required. This also applies to most
other viruses, whose inner structural proteins are commonly
translated from individual mRNAs on free polysomes in the
cytoplasm and subsequently recruited to their respective bud-
ding membrane by speciﬁc targeting signals.
Such recruitment of inner structural proteins to the budding
site may be facilitated by their speciﬁc interaction with the
cytoplasmic tail of viral transmembrane proteins. Pre-assem-
bled cytosolic capsids of Foamy Virus or the retrovirus Ma-
son-Pﬁzer Monkey Virus (M-PMV) speciﬁcally traﬃc to
intracellular membranes enriched in viral glycoproteins, where
budding occurs [29,30]. Direct interaction of core and mem-
brane glycoproteins is likely to occur during budding of all
enveloped viruses in order to assure formation of a complete
virion, but speciﬁc binding may be weak and contribute to
budding only in multimeric complexes. Incorporation of glyco-
proteins into VLPs may even occur without speciﬁc interac-
tion. Striking examples are retroviruses, which can be
functionally pseudotyped (i.e. incorporate heterologous mem-
brane proteins) with glycoproteins from completely unrelated
virus families (summarized in [31]), making a speciﬁc interac-
tion of inner structural and viral membrane proteins highly un-
likely. Moreover, the predominant steady-state localizations of
inner viral structural proteins and glycoproteins often only
partially overlap. In summary, speciﬁc interaction of viral
membrane glycoproteins and inner core proteins are rarely suf-
ﬁcient to anchor core proteins to the budding membrane and
trigger virion formation. Other mechanisms are likely to be re-
quired to target viral proteins towards selected membranes as
described below.5. Membrane targeting of inner viral structural matrix proteins
Many viral structural proteins acquire covalent modiﬁca-
tions that allow interaction with cellular membranes or mem-
brane microdomains. For instance, the major structural Gag
proteins of many retroviruses, as well as Z proteins of arenav-
iruses, are modiﬁed by myristic acid, which is covalently at-
tached to their N-terminus. N-terminal acylation has long
been proposed to promote membrane attachment of otherwise
soluble proteins in a reversible and regulated manner by adopt-
ing an exposed or sequestered conformation (‘myristyl switch’;[32]). A substantial amount of studies indicates that this mech-
anism applies to the myristoylated matrix protein of HIV [33–
36]. Mutational analysis has shown that membrane association
is abrogated by deletion of the myristyl anchor of Gag, con-
ﬁrming the importance of acylation for membrane binding.
The relatively weak binding energy provided by a myristyl an-
chor alone (8 kcal/mol, corresponding to a dissociation con-
stant of 104 M) [37] is, however, insuﬃcient to stably bind a
soluble protein to a lipid bilayer and additional binding forces
are needed to provide suﬃcient binding energy. Several retrovi-
ral Gag polyproteins have been proposed or shown to contain a
cluster of basic amino acids in addition to N-terminal acylation
[36,38]. Basic patches appear to be a conserved feature of retro-
viral matrix proteins, including those that are not myristoylated
[39,40]. Generally, basic residues can serve to strengthen mem-
brane binding by ionic interaction with the head groups of
acidic phospholipids. This interaction contributes a binding en-
ergy of approx. 1.4 kcal/mol per lysine, and the total binding
energy of these basic patches therefore generally equals or ex-
ceeds that of the acyl group. In addition, positively charged res-
idues also appear to determine speciﬁcity of plasma membrane
attachment, as HIV Gag is redirected towards intracellular
membranes upon mutation or deletion of the basic patch
[41,42]. In summary, acylation confers membrane binding abil-
ity to proteins, whereas basic clusters increase membrane aﬃn-
ity and binding speciﬁcity [37,43].
Recent ﬁndings have shown that the binding speciﬁcity med-
iated by the basic cluster may be due to interaction with speciﬁc
host cell phospholipids. Depletion of phosphatidylinositol–
(4,5) bisphosphate (PI(4,5)P2), which contains four acidic
charges and is concentrated on the plasma membrane, led to
the relocalization of HIV Gag to intracellular membranes
[44]. PI(4,5)P2 serves as plasma membrane targeting factor
for various cellular proteins and it may thus not be surprising
that viral matrix and core proteins make use of this mechanism
as well. N-terminal acylation in combination with a basic clus-
ter appears to be the common feature of this targeting mecha-
nism with a recent report showing that several myristylated
proteins with N-terminal basic patches, including HIV Gag,
speciﬁcally interact with PI(4,5)P2 and PI(3,4,5)P3, but not
with phosphoinositides that concentrate on endosomal or Gol-
gi membranes [45]. Structural analysis of the N-terminal do-
main of HIV-1 Gag, bound to a truncated version of
PI(4,5)P2, suggested that the speciﬁcity of interaction – at least
in this case – not only depends on ionic interactions of lysine
residues with multiple acidic charges, but also involves inser-
tion of a lipid chain of PI(4,5)P2 into a hydrophobic groove
of the viral protein. This interaction may not only be important
for plasma membrane binding in general, but also contribute to
the sorting of viral structural protein into liquid-ordered mem-
brane microdomains ([46], see below). It will be interesting to
see whether other viral matrix proteins with basic clusters em-
ploy a similar mechanism or if plasma membrane binding relies
primarily on ionic interactions with PI(4,5)P2 in such cases.6. Viral lipids and role of membrane microdomains
An important determinant for the lipid composition of the
viral envelope is the composition of the cellular membrane
the virus buds from [47,48]. It has long been known, however,
that the lipid composition of the viral and cellular membrane
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that some viruses selectively bud from membrane microdo-
mains. Such microdomains may serve as budding platforms
where viral transmembrane and core proteins are concen-
trated. Obvious candidates for such microdomains are the
so-called lipid rafts, highly enriched in cholesterol, sphingoli-
pids, and phospholipids with saturated side chains [55]. Several
viruses were proposed to bud from lipid rafts [56,57], although
these data suﬀer from the fact that the in vivo existence of raft
microdomains has not been unequivocally proven. Instead,
resistance to extraction with cold detergent is often taken as
proxy for lipid rafts. Accordingly, sorting of proteins into
detergent-resistant membranes (DRM; [58]) was suggested to
indicate their raft localization. Incorporation of DRM mark-
ers into the envelope of, e.g. Inﬂuenza, Sendai-, Measles, Ebola
virus and several retroviruses including HIV-1 (or co-localiza-
tion of viral glycoproteins with DRM markers) has been taken
as evidence for virus budding from rafts [57]. DRM may, how-
ever, comprise a heterogeneous population of microdomains,
clustered together by extraction with cold detergent, since bud-
ding of viruses supposed to bud from lipid rafts as well as from
non-raft regions of the plasma membrane is aﬀected by choles-
terol depletion [59–61]. Recently, the complete lipid composi-
tion of puriﬁed HIV-1 particles has been determined without
any detergent treatment [62]. The viral lipidome was shown
to be very similar to the suggested composition of lipid rafts
with a strong enrichment of cholesterol, sphingolipids includ-
ing the unusual lipid dihydro-sphingomyelin as well as phos-
pholipids with saturated side chains. Interestingly, HIV-1
particles excluded a bona ﬁde DRM marker (ﬂotillin 1) indi-
cating that the virus buds from a certain subset of cellular
microdomains. It is currently not known, however, whether
these microdomains are preexisting or virus-induced, and anal-
yses of the lipid composition of viruses with diﬀerent budding
preferences and derived from diﬀerent host cells will be impor-
tant to further our understanding.
Little is currently known about the sorting of viral structural
proteins into lipid microdomains. Cellular signal transduction
proteins that may be associated with lipid rafts are often found
to be myristoylated as well as palmitoylated (reviewed in
[63,64]). Double acylation has however not been reported for
viral proteins involved in budding from DRM, indicating that
a diﬀerent sorting mechanism is involved. Structural analysis
of the HIV-1 matrix domain in a complex with a soluble deriv-
ative of PI(4,5)P2 provided an intriguing suggestion: in this
structure the 2 0 acyl chain was buried within a hydrophobic
groove of the protein, while the 1 0 acyl chain, which extends
in the opposite direction, would be free to insert into a lipid bi-
layer [46]. Since the 2 0 chain is usually unsaturated while the 1 0
chain is saturated, sequestration of the 2 0 acyl chain by matrix
could promote the association of PI(4,5)P2 with liquid ordered
lipid microdomains. Thus, interaction with PI(4,5)P2 may help
to explain binding of the viral Gag protein to the plasma mem-
brane (see above) as well as its sorting into microdomains with
a high content of saturated fatty acids.
Lipid microdomains may also be organized by cellular pro-
teins, and viral budding platforms could thus be deﬁned by
interaction of viral structural proteins with these organizers.
The so-called tetraspanins (proteins with four membrane-span-
ning domains) have been proposed to interact laterally to form
tetraspanin-enriched microdomains (TEM) within the plasma
membrane and some intracellular membranes (reviewed in[65]). Several tetraspanins have been shown to be incorporated
into HIV-1 particles [1,66] and a recent study showed co-local-
ization of HIV-1 Gag with TEM [67], suggesting that TEM
may serve as platforms for virus budding. In summary, there
is accumulating evidence that virus budding – at least in some
cases – occurs from specialized membrane microdomains,
which may be preexisting or virus-induced and may be orga-
nized by their own lipid composition or by viral and/or cellular
proteins. Most likely, a combination of these mechanisms may
commonly apply, with diﬀerences between virus families. Fu-
ture studies of the composition, regulation and function of
virus budding microdomains will probably yield important in-
sights into the organization of such cellular membrane micro-
domains.7. Cellular factors involved in virus budding and release
While it was initially believed that virus budding is entirely
driven by viral factors, more recent work has shown a require-
ment for cellular functions in this process. Initial evidence for
the involvement of cellular activities came from studies, which
showed that mutation of short peptide motifs in retroviruses
lead to an arrest of virus replication at the late stage of bud-
ding [68,69]. These motifs were termed late domains, as late
domain defective variants commonly exhibited almost com-
pletely budded virions which remained tethered to the cell by
a thin membrane stalk. Various late domain motifs were iden-
tiﬁed in retroviruses, ﬁloviruses, arenaviruses, rhabdoviruses,
paramyxoviruses, reoviruses and ﬂaviviruses and in most in-
stances functionally conﬁrmed (reviewed in [70,71]). Two dif-
ferent types of late domains (consensus sequences PS/TAP
and YPDL) are known to interact with components of the
endosomal sorting complex required for transport (ESCRT;
TSG101 and AIP1/ALIX, respectively), while a third late do-
main (consensus sequence PPxY) was shown to interact with
ubiquitin ligases of the NEDD4 family. These results suggested
that both ESCRT and mono-ubiquitination play a role in virus
budding. Studies in paramyxoviruses revealed a fourth type of
late motif (sequence FPIV; [72]), but its interaction partner is
currently unknown.
ESCRT was originally identiﬁed in the budding yeast Sac-
charomyces cerevisiae, where it functions in sorting of proteins
destined for degradation into the intralumenal vesicles (ILV)
of MVB upon sequential recruitment of ESCRT-I, -II and -
III subcomplexes to endosomal membranes (Fig. 3). ESCRT
function is conserved in mammalian cells, where it mediates
sorting of mono-ubiquitinated cell surface receptors into
MVB (Fig. 3; [73]). Knockout of ESCRT components in yeast
and blocking of ESCRT function in mammalian cells led to
formation of an enlarged vacuole or MVB lacking ILV (class
E compartment) [74,75], indicating that ESCRT predomi-
nantly functions in budding of ILV into the lumen of MVB.
For details on the composition and function of ESCRT com-
plexes the reader is referred to several recent reviews [73,76–
78].
HIV-1 mutants defective in recruiting the ESCRT-I compo-
nent TSG101 exhibit a late budding phenotype, suggesting that
ESCRT provides a cellular budding machinery for HIV-1 [79].
Further studies using dominant negative ESCRT mutants and
siRNA-mediated knockdown indicated a requirement for com-
ponents of ESCRT-I and -III in budding of HIV-1 and several
Fig. 3. ESCRT plays a role in the formation of intralumenal MVB
vesicles and in retroviral budding. (A) The endosomal sorting complex
required for transport (ESCRT) functions in sorting of ubiquitinated
cell surface receptors destined for degradation into the ILV of MVB.
For several retroviruses (as well as other viruses – see text), the
topologically equal process of virus budding (away from the cyto-
plasm) was shown to depend on ESCRT as well. Viral Gag proteins
were shown to bind ESCRT, thereby recruiting it to the budding site.
(B) ESCRT subcomplexes are sequentially recruited to the retroviral
budding site. ESCRT-0 binding to membranes is facilitated by the
binding to PI(3)P and ubiquitinated proteins such as retroviral Gag,
respectively. This is followed by recruitment of ESCRT-I and/or AIP1/
ALIX by retroviral proteins. AIP1/ALIX binds both ESCRT-I and -
III, which ﬁnally recruits the ATPase VPS4. VPS4 ATPase activity is
believed to be required for the release of ESCRT-III into the cytosol
and to facilitate budding of the virus. The ESCRT-II subcomplex is
clearly required for ILV formation, but its involvement in virus
budding is unclear. Ub, ubiquitin. MVB, multivesicular body.
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formation at the MVB – appears to be dispensable for HIV-1
budding [80], indicating that enveloped viruses have usurped
only part of the cellular ESCRT machinery for their budding.
The extensive amount of primary data on the role of ESCRT
in virus budding is summarized in a number of excellent re-
views [70,71,81–83]. In general, ESCRT-I is required for bud-
ding of viruses with a PS/TAP late domain, whereas it appears
to be dispensable for viruses containing a PPxY late domain.
In contrast, budding of almost all viruses with known late do-
main functions appears to depend on the ATPase VPS4, be-
lieved to resolve the ESCRT-III complex as a ﬁnal step in
vesicle budding [75,84,85]. This diﬀerential dependence sug-
gests diﬀerent or partially overlapping entry points of various
viral late domains into the ESCRT pathway. The PPxY latedomain has been shown to interact with cellular E3 ubiquitin
ligases of the NEDD4 family, and mono-ubiquitination is be-
lieved to be important for virus release in this case (reviewed in
[70,83]). Mono-ubiquitination as well as ESCRT-function are
also essential for sorting of cell surface molecules into MVB
with several ESCRT components being ubiquitinated and/or
containing ubiquitin interaction motifs. These observations
suggest that reversible ubiquitination in MVB sorting may
serve to stabilize protein-interactions to form a transient pro-
tein web. A similar role for mono-ubiquitination may also be
envisaged for viral budding: Ubiquitinated viral proteins
may interact with ubiquitin-binding components of the
ESCRT pathway, and this interaction may serve as entry point
into the ESCRT pathway for viruses that lack direct ESCRT-
interacting motifs. Mono-ubiquitination also occurs for
viruses lacking a known E3-ligase recruitment motif and may
aid in virus budding in these cases as well [86,87]. It should
be noted, however, that the relative importance of ubiquitina-
tion and of individual ubiquitination sites has not been as-
sessed in detail for any virus so far.
Several viruses harbour multiple closely spaced or overlap-
ping late motifs. In these cases, the PPxY motif always appears
to be dominant, while the other late motif(s) contribute to re-
lease to a lesser extent [88–90]. Interestingly, mutation of the
PT/SAP motif in case of Mason-Pﬁzer Monkey Virus (M-
PMV) and Human T-Cell Leukemia Virus type I caused the
typical late budding arrest described above, while mutation
of the closely spaced PPxY late domain motif led to formation
of membrane-proximal complete capsids which apparently
failed to induce membrane curvature. These results suggest a
participation of ESCRT in the induction of curvature – i.e.
as a membrane scaﬀold – in these cases, which may be sup-
ported by the recently determined structure of the ESCRT-
III component CHMP3 [91], which was shown to multimerize
as a curved protein lattice. In the case of HIV-1 and other
viruses, on the other hand, ESCRT appears to be important
for membrane ﬁssion with no apparent eﬀect of a late domain
mutation on curvature induction. It is diﬃcult to envisage a
diﬀerential contribution of the same cellular factors to budding
of diﬀerent viruses, and further studies will hopefully allow
generating a uniﬁed picture. Late domain motifs have also
been identiﬁed in Foamy Virus and HBV [92–94], which are
believed to bud into the ER or pre-Golgi compartment, respec-
tively, suggesting that ESCRT may be recruited to and func-
tion at membranes where it is normally not present. Finally,
the lack of known late domains in many enveloped viruses
raises the question whether they use other entry points into
the same pathway or whether entirely diﬀerent mechanisms
of budding exist. This clearly warrants further studies.8. Conclusions and open questions
Early models of enveloped virus budding suggested that (i)
budding is generally driven by the interaction of viral trans-
membrane proteins with the inner core structure, (ii) mem-
brane bending occurs mainly by wrapping the cellular bilayer
around a pre-formed or concomitantly assembling viral core
or matrix layer, and (iii) ﬁssion of viral and cellular membranes
occurs by default. Evidence accumulated over the past years
indicated, however, that the process of budding is much more
complex: Depending on the virus, the driving forces may act
S. Welsch et al. / FEBS Letters 581 (2007) 2089–2097 2095on either side, or on both sides, of the membrane and there is
some evidence for cellular (scaﬀolding) proteins also being in-
volved in this process. Targeting of virion components to spe-
ciﬁc membrane systems or lipid microdomains as well as the
organization of microdomains (featuring a high concentration
of viral proteins) by cellular or viral factors may promote
assembly of complex structures, based on the synergy of multi-
ple weak interactions. The nature and role of such microdo-
mains remained largely elusive due to a lack of suitable tools
for their investigation. However, recent technology advances
like ﬂuorescence resonance energy transfer, high resolution
light microscopy and cryo-electron tomography are likely to
overcome some of these diﬃculties.
The mechanisms of membrane distortion early in virus
budding are poorly understood, but are also likely to require
cooperation of viral and cellular factors. Quantitative analy-
ses in conjunction with mathematical modelling and simula-
tion of membrane bending and curvature induction will
shed more light on this process in the future. While it is rea-
sonable to assume that lateral interaction between viral struc-
tural proteins can provide energy for membrane bending,
experimental evidence also points to a requirement for cellu-
lar machineries at least in some viral systems. For example,
BAR domain proteins such as endophilins or amphiphysins,
implicated to induce membrane curvature, were recently pro-
posed to play a role during virus budding [95]. Moreover,
speciﬁc lipids may play a role in membrane bending: the
ESCRT protein AIP1/ALIX – recruited by some viral late
domains – was found to speciﬁcally interact with the cone-
shaped lipid LBPA in vitro [96] and LBPA was therefore
suggested to modulate membrane curvature during ILV for-
mation at the MVB. It should be noted, however, that LBPA
appears to be restricted to endosomal membranes and cone-
shaped lipids have not been reported in the plasma membrane
so far.
Diﬀerent studies have indicated a role of ESCRT both very
early during virus budding as well as during the last pinching-
oﬀ step: mutations of late domain motifs in Human T-cell Leu-
kemia Virus and M-PMV arrested budding at a stage before
induction of membrane curvature [89,97], whereas other late
domain mutations arrested virus budding at a very late stage.
An important functional role of ESCRT in both membrane
bending and membrane ﬁssion is consistent with its involve-
ment in the topologically equivalent process of vesicle budding
at the MVB. From what is currently known it can be proposed,
however, that mechanistic diﬀerences between viral and cellu-
lar pathways, as well as between pathways used by diﬀerent
viruses, exist. Detailed analyses of these pathways and compar-
ative studies of the envelopment of viral and cellular structures
are likely to yield many more important insights.
Historically, cell biology and virology were closely con-
nected ﬁelds with an immense mutual beneﬁt, but this associa-
tion has weakened over the years. Studying viral membrane
envelopment may serve to re-establish a fruitful co-operation
of these two ﬁelds in the future.
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